Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BUXXNASDAQ:FINENYSE:JPINASDAQ:MNTL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBUXXStrive Enhanced Income Short Maturity ETF$20.32$20.33$20.16▼$20.49$274.73M0.02241,413 shs263,927 shsFINEThemes European Luxury ETF$22.59+1.5%$22.09$17.78▼$25.00$678K0.75395 shs1,491 shsJPINuveen Preferred and Income Term Fund$20.80$20.35$17.20▼$21.42N/AN/A46,407 shs35,790 shsMNTLTema Neuroscience and Mental Health ETF$22.57+0.3%$22.50$19.86▼$27.66$9.93M0.99430 shs26 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBUXXStrive Enhanced Income Short Maturity ETF0.00%-0.34%+0.10%-0.05%+0.49%FINEThemes European Luxury ETF+2.09%+0.68%+0.68%+8.21%-1.31%JPINuveen Preferred and Income Term Fund+0.48%+1.76%+2.51%+5.74%+6.94%MNTLTema Neuroscience and Mental Health ETF+0.61%-0.52%+2.97%-0.02%-12.33%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBUXXStrive Enhanced Income Short Maturity ETFN/AN/AN/AN/AN/AN/AN/AN/AFINEThemes European Luxury ETFN/AN/AN/AN/AN/AN/AN/AN/AJPINuveen Preferred and Income Term FundN/AN/AN/AN/AN/AN/AN/AN/AMNTLTema Neuroscience and Mental Health ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBUXXStrive Enhanced Income Short Maturity ETF 0.00N/AN/AN/AFINEThemes European Luxury ETF 2.11Hold$22.59N/AJPINuveen Preferred and Income Term Fund 0.00N/AN/AN/AMNTLTema Neuroscience and Mental Health ETF 2.84Moderate Buy$22.57N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBUXXStrive Enhanced Income Short Maturity ETFN/AN/AN/AN/AN/AN/AFINEThemes European Luxury ETFN/AN/AN/AN/AN/AN/AJPINuveen Preferred and Income Term Fund$39.24MN/AN/AN/AN/AN/AMNTLTema Neuroscience and Mental Health ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBUXXStrive Enhanced Income Short Maturity ETFN/AN/A0.00∞N/AN/AN/AN/AN/AFINEThemes European Luxury ETFN/AN/A24.03∞N/AN/AN/AN/AN/AJPINuveen Preferred and Income Term FundN/AN/A0.00∞N/AN/AN/AN/AN/AMNTLTema Neuroscience and Mental Health ETFN/AN/A22.06∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBUXXStrive Enhanced Income Short Maturity ETF$1.055.17%N/AN/AN/AFINEThemes European Luxury ETF$0.210.93%N/AN/AN/AJPINuveen Preferred and Income Term Fund$1.858.89%N/AN/AN/AMNTLTema Neuroscience and Mental Health ETF$0.251.11%N/AN/AN/ALatest BUXX, JPI, FINE, and MNTL DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/3/2025JPINuveen Preferred and Income Term Fundmonthly$0.16609.8%6/13/20256/13/20257/1/20255/2/2025JPINuveen Preferred and Income Term Fundmonthly$0.16609.9%5/15/20255/15/20256/2/20254/3/2025JPINuveen Preferred and Income Term Fundmonthly$0.166010.2%4/15/20254/15/20255/1/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBUXXStrive Enhanced Income Short Maturity ETFN/AFINEThemes European Luxury ETFN/AJPINuveen Preferred and Income Term FundN/AMNTLTema Neuroscience and Mental Health ETFN/AInsider OwnershipCompanyInsider OwnershipBUXXStrive Enhanced Income Short Maturity ETFN/AFINEThemes European Luxury ETFN/AJPINuveen Preferred and Income Term FundN/AMNTLTema Neuroscience and Mental Health ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBUXXStrive Enhanced Income Short Maturity ETFN/A13.52 millionN/ANot OptionableFINEThemes European Luxury ETFN/A30,000N/AN/AJPINuveen Preferred and Income Term FundN/AN/AN/AN/AMNTLTema Neuroscience and Mental Health ETFN/A440,000N/AN/ABUXX, JPI, FINE, and MNTL HeadlinesRecent News About These CompaniesHone Your Biotech Allocation in Neuroscience ETF MNTLDecember 12, 2024 | etftrends.comENew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir SoonIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI DefenseIntel's Turnaround Strategy Shifts From Planning to Attack ModeBy Jeffrey Neal Johnson | June 20, 2025View Intel's Turnaround Strategy Shifts From Planning to Attack Mode3 Biotech Stocks to Watch: Iovance, Neurocrine & VikingBy Chris Markoch | June 29, 2025View 3 Biotech Stocks to Watch: Iovance, Neurocrine & VikingBUXX, JPI, FINE, and MNTL Company DescriptionsStrive Enhanced Income Short Maturity ETF NYSE:BUXX$20.32 0.00 (0.00%) As of 07/1/2025 04:00 PM EasternThe Strive Enhanced Income Short Maturity ETF (BUXX) is an exchange-traded fund that mostly invests in broad credit fixed income. The fund is actively managed, investing in a portfolio of various fixed-income securities of any credit rating from issuers all around the globe. The fund aims for a dollar-weighted average maturity of less than two years BUXX was launched on Aug 10, 2023 and is issued by Alpha Architect.Themes European Luxury ETF NASDAQ:FINE$22.59 +0.34 (+1.53%) As of 07/1/2025 03:25 PM EasternThe Themes European Luxury ETF (FINE) is an exchange-traded fund that is based on the Solactive European Luxury index. The fund tracks an index comprised of companies in Developed Europe that offer luxury goods and services. The index selects and weights holdings towards those companies with most business exposure related to the investment theme FINE was launched on Dec 13, 2023 and is issued by Themes.Nuveen Preferred and Income Term Fund NYSE:JPI$20.80 0.00 (0.00%) Closing price 07/1/2025 03:52 PM EasternExtended Trading$20.42 -0.38 (-1.82%) As of 07/1/2025 04:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nuveen Preferred and Income Term Fund is a close ended balanced mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests into public equity and fixed income markets across the globe. The fund seeks to invest in stocks of companies that are operating in financial services sectors such as bank, insurance, REITs, and utility companies. It primarily invests in preferred securities and other income producing securities including debt securities, hybrid securities, and convertible securities. At least 60% of the fund's assets are rated investment grade i.e. BBB/Baa or better by one of the nationally recognized statistical rating organizations. It employs fundamental and quantitative analysis, with focus a on bottom-up fundamental credit research to create its portfolio. The fund benchmarks the performance of its portfolio against the Bank of America/Merrill Lynch Preferred Stock Fixed Rate Index. Nuveen Preferred and Income Term Fund was founded on July 26, 2012 and is domiciled in the United States.Tema Neuroscience and Mental Health ETF NASDAQ:MNTL$22.57 +0.08 (+0.34%) Closing price 07/1/2025 03:02 PM EasternExtended Trading$22.56 0.00 (0.00%) As of 07/1/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Tema Neuroscience and Mental Health ETF (MNTL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, concentrating on companies engaged in addressing disorders of the central nervous system and mental health worldwide. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. MNTL was launched on Jan 22, 2024 and is issued by Tema. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 2 Reasons to Buy Trade Desk Stock Now and 1 Warning Sign Toast Stock: A Fast-Growing Mid-Cap Eyeing Further Upside Breakout Alert: Disney Stock Hits Multi-Year High 2 Under the Radar Space & Defense Stocks With Huge Potential Palantir’s $100M Nuclear OS Pact Boosts Bullish Case Forget IBM: Accenture’s AI Momentum Is Your Next Buy Joby Stock Soars as Piloted Flights in Dubai Signal a New Era Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
